Search Results - "Eckersley, Sonia"
-
1
Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies
Published in PloS one (06-09-2016)“…Ulcerative colitis is a chronic inflammatory disease affecting the colon and is characterized by epithelial damage and barrier dysfunction. Upregulation of the…”
Get full text
Journal Article -
2
Identification of a Subset of Human Non-Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma
Published in Clinical cancer research (01-02-2014)“…The phosphoinositide 3-kinase (PI3K) pathway is a major oncogenic signaling pathway and an attractive target for therapeutic intervention. Signaling through…”
Get full text
Journal Article -
3
Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease
Published in Journal of Alzheimer's disease (01-01-2013)“…The appearance of neurofibrillary tangles (NFT), one of the major hallmarks of Alzheimer's disease (AD), is most likely caused by inappropriate phosphorylation…”
Get more information
Journal Article -
4
The Use of Antibodies in Small-Molecule Drug Discovery
Published in Journal of biomolecular screening (01-07-2014)“…Antibodies are powerful research tools that can be used in many areas of biology to probe, measure, and perturb various biological structures. Successful drug…”
Get more information
Journal Article -
5
Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours
Published in Virchows Archiv : an international journal of pathology (01-03-2013)“…BRCA1 protein measurement has previously been evaluated as a potential diagnostic marker without reaching a conclusive recommendation. In this study, we…”
Get full text
Journal Article -
6
Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα
Published in Bioscience reports (23-08-2013)“…TNFα (tumour necrosis factor α) is an early mediator in the systemic inflammatory response to infection and is therefore a therapeutic target in sepsis…”
Get full text
Journal Article -
7